Cadisch R, Streit E, Hartmann K
Medizinische Klinik, Kantonsspital Luzern, Chur.
Schweiz Med Wochenschr. 1996 Feb 24;126(8):308-10.
We report the case of a 25-year-old female patient with severe aggravation of myasthenia gravis due to azithromycin which was prescribed for an influenza syndrome. One hour after the intake of 500 mg azithromycin the patient developed weakness of the legs and respiratory distress due to respiratory muscle failure. She was hospitalized in a comatose state and required intubation and mechanical ventilation for six days. Acute worsening of myasthenia gravis was observed in this patient in 1986 after parenteral administration of erythromycin. Erythromycin causing aggravation of myasthenia gravis by interfering with neuromuscular transmission is reported in the literature. The close temporal relationship between the intake of azithromycin and severe worsening of myasthenia gravis in our patient suggests that azithromycin, a new azalid-antibiotic of the macrolid group, can exacerbate myasthenia gravis. We conclude that azithromycin should be added to the list of drugs to be used with caution in patients with myasthenia gravis.
我们报告了一例25岁女性患者的病例,该患者因患流感综合征而服用阿奇霉素后,重症肌无力病情严重加重。在服用500毫克阿奇霉素一小时后,患者因呼吸肌无力出现腿部无力和呼吸窘迫。她以昏迷状态入院,需要插管并进行六天的机械通气。该患者曾在1986年静脉注射红霉素后出现重症肌无力急性加重。文献报道红霉素可通过干扰神经肌肉传递而加重重症肌无力。在我们的患者中,阿奇霉素摄入与重症肌无力严重恶化之间的密切时间关系表明,作为大环内酯类新的氮杂内酯类抗生素,阿奇霉素可加重重症肌无力。我们得出结论,阿奇霉素应被列入重症肌无力患者需谨慎使用的药物清单。